1. Home
  2. CPAY vs ILMN Comparison

CPAY vs ILMN Comparison

Compare CPAY & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corpay Inc.

CPAY

Corpay Inc.

HOLD

Current Price

$317.75

Market Cap

22.5B

Sector

Technology

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$119.02

Market Cap

20.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPAY
ILMN
Founded
1986
1998
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.5B
20.4B
IPO Year
2010
2000

Fundamental Metrics

Financial Performance
Metric
CPAY
ILMN
Price
$317.75
$119.02
Analyst Decision
Buy
Hold
Analyst Count
11
17
Target Price
$378.91
$124.24
AVG Volume (30 Days)
687.6K
1.9M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
7.59
170.87
EPS
15.03
5.45
Revenue
$4,528,403,000.00
$4,343,000,000.00
Revenue This Year
$18.85
$6.52
Revenue Next Year
$10.52
$5.49
P/E Ratio
$21.36
$21.19
Revenue Growth
13.93
N/A
52 Week Low
$252.84
$68.70
52 Week High
$361.99
$155.53

Technical Indicators

Market Signals
Indicator
CPAY
ILMN
Relative Strength Index (RSI) 44.62 40.20
Support Level $314.57 $114.88
Resistance Level $338.47 $135.68
Average True Range (ATR) 11.07 4.53
MACD -1.97 -0.34
Stochastic Oscillator 23.08 19.13

Price Performance

Historical Comparison
CPAY
ILMN

About CPAY Corpay Inc.

Corpay Inc is a corporate payments company that helps businesses and consumers manage and pay their expenses. The company offers payment and spend management solutions, including accounts payable automation, cross-border payments, commercial card programs, vehicle payment solutions, and lodging payment services. Its reportable segments are: Corporate Payments, Vehicle Payments, Lodging Payments and Other. The majority of the company's revenue is derived from the Vehicle Payments segment, which helps customers to pay for vehicle related expenses. Geographically, it derives the maximum revenue from the United States and the rest from Brazil, the United Kingdom and other countries.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: